These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6115031)

  • 1. Whole brain tyrosine hydroxylase activity during the development of deoxycorticosterone acetate-1% sodium chloride-induced hypertension in rats.
    Jackson N; Gulliver PA; Dean HG
    J Pharm Pharmacol; 1981 Jul; 33(7):445-50. PubMed ID: 6115031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain tyrosine hydroxylase activity and systolic blood pressure in rats treated with either deoxycorticosterone and salt or angiotensin.
    Rylett P; Dean HG; Lee MR
    J Pharm Pharmacol; 1976 Jul; 28(7):559-62. PubMed ID: 8609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Blockade of Brain Endothelin Receptor Type-A (ET
    Cassinotti LR; Guil MJ; Schöller MI; Navarro MP; Bianciotti LG; Vatta MS
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term changes in rat brain tyrosine hydroxylase following reserpine treatment: a quantitative immunochemical analysis.
    Labatut R; Buda M; Bérod A
    J Neurochem; 1988 May; 50(5):1375-80. PubMed ID: 2896228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of chronically administered thyrotropin-releasing hormone (TRH) on regional rat brain tyrosine hydroxylase activity.
    Nemeroff CB; Diez JA; Bissette G; Prange AJ; Harrell LE; Lipton MA
    Pharmacol Biochem Behav; 1977 Apr; 6(4):467-9. PubMed ID: 18744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of reserpine on activities and amounts of tyrosine hydroxylase and dopamine-beta-hydroxylase in catecholamine neuronal systems in rat brain.
    Reis DJ; Joh TH; Ross RA
    J Pharmacol Exp Ther; 1975 Jun; 193(3):775-84. PubMed ID: 239215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and vascular monoamine oxidase activity in the deoxycorticosterone-salt hypertensive rat.
    Lai FM; Spector S
    Br J Pharmacol; 1977 Mar; 59(3):393-5. PubMed ID: 843681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clonidine on tyrosine hydroxylase activity in the adrenal medulla and brain of spontaneously hypertensive rats.
    Moura E; Afonso J; Serrão MP; Vieira-Coelho MA
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):113-21. PubMed ID: 19067675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of guanethidine and hydrochlorothiazide on blood pressure and vascular tyrosine hydroxylase activity in the spontaneously hypertensive rat.
    Kohler C; Berkowitz B; Spector S
    Eur J Pharmacol; 1977 Mar; 42(2):161-9. PubMed ID: 14839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic imipramine administration alters the activity and phosphorylation state of tyrosine hydroxylase in dopaminergic regions of rat brain.
    Rosin DL; Melia K; Knorr AM; Nestler EJ; Roth RH; Duman RS
    Neuropsychopharmacology; 1995 Apr; 12(2):113-21. PubMed ID: 7779239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-specific alterations in tyrosine hydroxylase activity in rats exposed to lead.
    Ramesh GT; Jadhav AL
    Mol Cell Biochem; 1998 Dec; 189(1-2):19-24. PubMed ID: 9879649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments.
    Melia KR; Rasmussen K; Terwilliger RZ; Haycock JW; Nestler EJ; Duman RS
    J Neurochem; 1992 Feb; 58(2):494-502. PubMed ID: 1345939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in responsiveness of noradrenergic neurons of the locus coeruleus in deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Berecek KH; Olpe HR; Mah SC; Hofbauer KG
    Brain Res; 1987 Jan; 401(2):303-11. PubMed ID: 2880643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of the nucleus locus coeruleus in DOCA-salt hypertensive rats.
    Chida K; Kawamura H; Hatano M
    Brain Res; 1983 Aug; 273(1):53-8. PubMed ID: 6616232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of protein and peptide hydrolases in DOCA-salt hypertensive rat treated with chlorthalidone.
    Santos-Costa JL; Bissoli NS; Cabral AM; Cicilini MA
    Braz J Med Biol Res; 1996 Nov; 29(11):1431-5. PubMed ID: 9196540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal elevation of brain tyrosine hydroxylase activity, without concurrent increases in steady-state catecholamine levels, resulting from dl-alpha-methylparatyrosine administration during embryonic development.
    Lydiard RB; Fossom LH; Sparber SB
    J Pharmacol Exp Ther; 1975 Jul; 194(1):27-36. PubMed ID: 239220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Model of Dexamethasone-Induced Hypertension: Use in Investigating the Role of Tyrosine Hydroxylase.
    Soto-Piña AE; Franklin C; Rani CS; Gottlieb H; Hinojosa-Laborde C; Strong R
    J Pharmacol Exp Ther; 2016 Sep; 358(3):528-36. PubMed ID: 27405316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.